A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Almotriptan
Serotonin
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Serotonin.
Almotriptan
Lurasidone
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Lurasidone.
Almotriptan
Tofisopam
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Tofisopam.
Almotriptan
Cinitapride
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Cinitapride.
Almotriptan
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.
Almotriptan
Sulthiame
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Sulthiame.
Almotriptan
Wortmannin
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Wortmannin.
Almotriptan
Mebutamate
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Mebutamate.
Almotriptan
Benzyl alcohol
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Benzyl alcohol.
Almotriptan
Triclofos
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Triclofos.
Almotriptan
Ketobemidone
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Ketobemidone.
Almotriptan
Fospropofol
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Fospropofol.
Almotriptan
Dexmethylphenidate
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Dexmethylphenidate.
Almotriptan
Mepyramine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Mepyramine.
Almotriptan
Nitrous oxide
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Nitrous oxide.
Almotriptan
Vilazodone
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Vilazodone.
Almotriptan
Esmirtazapine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Esmirtazapine.
Almotriptan
Saredutant
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Saredutant.
Almotriptan
Safinamide
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Safinamide.
Almotriptan
Agomelatine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Agomelatine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3